News
DUSA offers a high conviction, value-focused approach with a concentrated portfolio. Learn more about DUSA ETF and my ...
EMA recommends Gilead Sciences' Lenacapavir for HIV prevention, with FDA approval and generic options available soon.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results